ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AZN Astrazeneca Plc

11,910.00
558.00 (4.92%)
Last Updated: 08:12:03
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  558.00 4.92% 11,910.00 11,916.00 11,924.00 12,086.00 11,850.00 11,890.00 234,395 08:12:03
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 29.55 175.98B
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 11,352p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 12,348.00p.

Astrazeneca currently has 1,550,189,338 shares in issue. The market capitalisation of Astrazeneca is £175.98 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 29.55.

Astrazeneca Share Discussion Threads

Showing 5226 to 5249 of 6150 messages
Chat Pages: Latest  210  209  208  207  206  205  204  203  202  201  200  199  Older
DateSubjectAuthorDiscuss
23/11/2021
11:10
BRYAN GARNIER CUTS ASTRAZENECA TO 'BUY' (CONVICTION BUY) - PRICE TARGET 10,500 PENCE

KEPLER CHEUVREUX CUTS ASTRAZENECA PRICE TARGET TO 9,500 (9,800) PENCE - 'BUY'

philanderer
23/11/2021
11:01
AstraZeneca's pledge to poorer nations as it seeks COVID jab profits from next year
philanderer
22/11/2021
10:23
And of course the numbers are far worse as 0-28 days after jabbing you're considered unvaccinated so all deaths from the jabs in that period aren't counted as jab deaths.

Ricky risk. No one addresses my comments sensibly . All I get are ad hominems. Why is that?

Moderate? Why do you only want good news. If the immunity from prosecution is ruled unlawful all those jab deaths and injuries would bankrupt any company. You better pray the fascism doesn't get taken down.

john nada
22/11/2021
10:07
Google "cherry picking". Does this platform have a moderator?
riskonricky
22/11/2021
08:49
LMFAO. Where's the accident data. Where's the jabbed vs unjabbed accident data?? The only data that can trusted is overall mortality as shown in the graph and the jabbed are dying at twice the rate. It's there in blue and brown.

Look I understand these facts are troubling. If you're a human and not a bot investing in a company like AZN is soul destroying.

john nada
22/11/2021
08:36
It starts during lockdown you numbskull. Of course people are having more accidents now they are doing something. Took me 10 seconds to work that out - Idiot.
riskonricky
22/11/2021
08:30
As Charlie Sheen famously said. WINNING.

That immunity from prosecution is a pretty neat trick big pharma managed to pull off. All those billions in pension payments avoided. Stunning business model.



Vaccinated English adults under 60 are dying at twice the rate of unvaccinated people the same age and have been for six months. This chart may seem unbelievable or impossible, but it's correct, based on weekly data from the British government.

The brown line represents weekly deaths from all causes of vaccinated people aged 10-59, per 100,000 people.

The blue line represents weekly deaths from all causes of unvaccinated people per 100,000 in the same age range.

I have checked the underlying dataset myself and this graph is correct. Vaccinated people under 60 are twice as likely to die as unvaccinated people. And overall deaths in Britain are running well above normal.

I don’t know how to explain this other than vaccine-caused mortality.

The basic data is available here, download the Excel file and see table 4:

john nada
18/11/2021
13:37
Greg, AZN have stated that a modest profit on vaccines going forward should
offset development costs on their antibody treatment. They don't appear to give
an indication this will be a strong profit generator for the business.

COVID obscures the high growth story emerging on the pharma side.

essentialinvestor
18/11/2021
12:56
The price has not been set for AZD7442 so how do you know that the profit is miniscule?
gregb
18/11/2021
12:53
Good shout!! - and given the minuscule profit on this re AZN it's illogical.
But that the market and there are algos at play,

Getting tempted to have a small amount.

essentialinvestor
18/11/2021
12:13
P,

And every time AZN mentions anything related to Covid it tanks!

beckers2008
18/11/2021
10:56
(Alliance News) - AstraZeneca PLC on Thursday said tests have confirmed effectiveness against Covid-19 from a one-time intramuscular dose of AZD7442 in high-risk populations.

The Cambridge, England-based pharmaceutical firm said new data from the AZD7442 Covid-19 Provent prevention and Tackle outpatient treatment phase III trials showed one 300 milligramme dose of AZD7442 reduced the risk of developing symptomatic Covid-19 compared to placebo by 83%.

The AZD7442 Provent trial is the first phase III trial designed to evaluate a monoclonal antibody for pre-exposure prophylaxis of symptomatic Covid-19, with targeted inclusion of high-risk and immunocompromised participants.

Astra highlighted that there were no cases of severe Covid-19 or Covid-19-related deaths in those treated with AZD7442 at either the primary or six-month analyses.

philanderer
17/11/2021
13:39
AZN in Oversold territory.

ASTRAZENECA : UBS reaffirms its Buy rating
11/17/2021 | 10:42am GMT

In a research note published by Michael Leuchten, UBS advises its customers to buy the stock. The target price remains set at GBX 10000.

ASTRAZENECA : Deutsche Bank reiterates its Buy rating
11/17/2021 | 12:09pm GMT

Deutsche Bank analyst Emmanuel Papadakis maintains his Buy rating on the stock. The target price remains set at GBX 10500.

beckers2008
17/11/2021
10:09
gullible thickies like Jimarilo crop up everywhere .
arja
17/11/2021
10:07
SOCGEN RAISES ASTRAZENECA PRICE TARGET TO 15,500 (15,000) PENCE - 'BUY'
philanderer
17/11/2021
03:00
Dr. David Martin
jimarilo
17/11/2021
02:58
People finally waking up to what is going on here........most people in hospital have been jabbed.....the jab is what put them there

This is not a vaccine, this is not a vaccine, this is not a vaccine

It is a gene therapy, that is designed to harm and kill you .....FACT!!

jimarilo
16/11/2021
21:32
bit more downside for AZN but getting close to chart support
arja
16/11/2021
18:49
Well I have just had a £10k bet. If its a none profit drug they are producing then whats the problem???
jackdaw4243
16/11/2021
15:11
Vaccine fury: 600,000 AstraZeneca doses thrown away after Covid jabs expired


The UK has been shamed after reportedly disposing of over 600,000 AstraZeneca vaccine doses after the COVID-19 jabs expired.

philanderer
16/11/2021
14:53
Monty, dangerous market ATM as if you miss expectations, a share price is whacked.

Lots of hot money in the market, coupled with hedge funds and algos which
can switch sides in the blink of an eye.

essentialinvestor
16/11/2021
14:48
Essential
Even a good company bought at the wrong price is a bad investment, no need to jump in yet.

montyhedge
16/11/2021
14:47
Tempted to buy in again but price now well under last week's low
so yesterday's bounce looks transitory.

essentialinvestor
16/11/2021
12:27
phil
About right.

montyhedge
Chat Pages: Latest  210  209  208  207  206  205  204  203  202  201  200  199  Older

Your Recent History

Delayed Upgrade Clock